25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Invion Ltd
Buy, Hold or Sell?

Let's analyze Invion Ltd together

I guess you are interested in Invion Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Invion Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Invion Ltd

I send you an email if I find something interesting about Invion Ltd.

1. Quick Overview

1.1. Quick analysis of Invion Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Invion Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-1.8%

For what price can you sell your share?

Current Price per Share
A$0.14
Expected price per share
A$0.105 - A$0.27
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Invion Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.14
Intrinsic Value Per Share
A$-0.02 - A$0.03
Total Value Per Share
A$-0.02 - A$0.03

2.2. Growth of Invion Ltd (5 min.)




Is Invion Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$9.1m$11.6m-$2.5m-27.4%

How much money is Invion Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$1m-$2.5m-71.3%
Net Profit Margin-152.3%-39.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Invion Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Invion Ltd?

Welcome investor! Invion Ltd's management wants to use your money to grow the business. In return you get a share of Invion Ltd.

First you should know what it really means to hold a share of Invion Ltd. And how you can make/lose money.

Speculation

The Price per Share of Invion Ltd is A$0.135. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Invion Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Invion Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Invion Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.4%0.00-0.4%0.00-0.1%0.00-0.2%0.00-1.2%
Usd Book Value Change Per Share0.00-0.3%0.00-0.3%0.00-0.2%0.000.1%0.00-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.3%
Usd Total Gains Per Share0.00-0.3%0.00-0.3%0.00-0.2%0.000.1%0.00-0.3%
Usd Price Per Share0.00-0.00-0.00-0.00-0.01-
Price to Earnings Ratio-4.57--4.57--15.90--27.92--24.75-
Price-to-Total Gains Ratio-6.47--6.47--11.95--333.65--187.17-
Price to Book Ratio1.78-1.78-1.40-5.82-6.44-
Price-to-Total Gains Ratio-6.47--6.47--11.95--333.65--187.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.085779
Number of shares11657
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (11657 shares)-4.581.86
Gains per Year (11657 shares)-18.327.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-18-2807-3
20-37-460154
30-55-6402211
40-73-8203018
50-92-10003725
60-110-11804532
70-128-13605239
80-147-15405946
90-165-17206753
100-183-19007460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.018.06.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%10.014.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%4.00.06.040.0%8.00.016.033.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%10.014.00.041.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Invion Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-46%0.000-346%-0.001+130%
Book Value Per Share--0.0020.0020%0.003-22%0.002+11%0.003-23%
Current Ratio--2.0532.0530%8.854-77%6.735-70%4.026-49%
Debt To Asset Ratio--0.0660.0660%0.034+92%0.066-1%0.205-68%
Debt To Equity Ratio--0.0700.0700%0.035+99%0.073-4%0.358-80%
Dividend Per Share----0%-0%-0%0.001-100%
Enterprise Value--25467339.27625467339.2760%29112655.272-13%46794195.279-46%45651085.025-44%
Eps---0.001-0.0010%0.000-71%0.000-56%-0.003+186%
Ev To Ebitda Ratio---5.571-5.5710%-30.157+441%-36.751+560%-26.885+383%
Ev To Sales Ratio--6.8946.8940%7.092-3%15.360-55%infnan%
Free Cash Flow Per Share---0.001-0.0010%-0.001+33%-0.001-2%-0.002+268%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.002-129%0.002-131%0.001-163%
Gross Profit Margin--1.8051.8050%1.697+6%2.028-11%1.533+18%
Intrinsic Value_10Y_max--0.025--------
Intrinsic Value_10Y_min---0.021--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max--0.002--------
Intrinsic Value_3Y_min---0.006--------
Intrinsic Value_5Y_max--0.007--------
Intrinsic Value_5Y_min---0.010--------
Market Cap9498018.960-171%25697628.27625697628.2760%25678378.272+0%44455723.679-42%45760068.225-44%
Net Profit Margin---1.523-1.5230%-0.393-74%-0.702-54%-10.775+607%
Operating Margin---1.458-1.4580%-0.402-72%-0.707-52%-13.103+798%
Operating Ratio--3.0443.0440%1.941+57%2.228+37%18.919-84%
Pb Ratio60.072+97%1.7801.7800%1.396+28%5.816-69%6.442-72%
Pe Ratio-154.110-3275%-4.566-4.5660%-15.902+248%-27.922+511%-24.749+442%
Price Per Share0.135+97%0.0040.0040%0.0040%0.008-47%0.011-64%
Price To Free Cash Flow Ratio-262.707-3275%-7.784-7.7840%-5.851-25%-27.391+252%-0.833-89%
Price To Total Gains Ratio-218.334-3275%-6.469-6.4690%-11.945+85%-333.653+5058%-187.167+2793%
Quick Ratio--1.9671.9670%8.762-78%6.662-70%3.943-50%
Return On Assets---0.364-0.3640%-0.085-77%-0.198-46%-0.306-16%
Return On Equity---0.390-0.3900%-0.088-77%-0.215-45%-0.485+25%
Total Gains Per Share---0.001-0.0010%0.000-46%0.000-346%-0.001+14%
Usd Book Value--9173696.7899173696.7890%11688948.022-22%7959935.630+15%5900142.993+55%
Usd Book Value Change Per Share--0.0000.0000%0.000-46%0.000-346%-0.001+130%
Usd Book Value Per Share--0.0010.0010%0.002-22%0.001+11%0.002-23%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Enterprise Value--16181947.37616181947.3760%18498181.160-13%29733031.681-46%29006699.425-44%
Usd Eps---0.001-0.0010%0.000-71%0.000-56%-0.002+186%
Usd Free Cash Flow---2097694.946-2097694.9460%-2788475.774+33%-2005742.908-4%-1995579.303-5%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+33%0.000-2%-0.001+268%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.001-129%0.001-131%0.001-163%
Usd Market Cap6035041.247-171%16328273.00716328273.0070%16316041.554+0%28247166.826-42%29075947.350-44%
Usd Price Per Share0.086+97%0.0030.0030%0.0030%0.005-47%0.007-64%
Usd Profit---3575881.881-3575881.8810%-1026058.534-71%-1514896.789-58%-2229123.179-38%
Usd Revenue--2347330.2622347330.2620%2608133.369-10%2147339.510+9%1387828.290+69%
Usd Total Gains Per Share--0.0000.0000%0.000-46%0.000-346%0.000+14%
 EOD+3 -5MRQTTM+0 -0YOY+9 -275Y+10 -2810Y+22 -17

3.3 Fundamental Score

Let's check the fundamental score of Invion Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-154.110
Price to Book Ratio (EOD)Between0-160.072
Net Profit Margin (MRQ)Greater than0-1.523
Operating Margin (MRQ)Greater than0-1.458
Quick Ratio (MRQ)Greater than11.967
Current Ratio (MRQ)Greater than12.053
Debt to Asset Ratio (MRQ)Less than10.066
Debt to Equity Ratio (MRQ)Less than10.070
Return on Equity (MRQ)Greater than0.15-0.390
Return on Assets (MRQ)Greater than0.05-0.364
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Invion Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.140
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Invion Ltd

Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, and solid cancers, such as lung, ovarian, anogenital, and glioblastoma multiforme cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Fundamental data was last updated by Penke on 2025-02-05 18:04:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Invion Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -152.3% means that $-1.52 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Invion Ltd:

  • The MRQ is -152.3%. The company is making a huge loss. -2
  • The TTM is -152.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-152.3%TTM-152.3%0.0%
TTM-152.3%YOY-39.3%-113.0%
TTM-152.3%5Y-70.2%-82.2%
5Y-70.2%10Y-1,077.5%+1,007.4%
4.3.1.2. Return on Assets

Shows how efficient Invion Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -36.4% Return on Assets means that Invion Ltd generated $-0.36 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Invion Ltd:

  • The MRQ is -36.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -36.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.4%TTM-36.4%0.0%
TTM-36.4%YOY-8.5%-27.9%
TTM-36.4%5Y-19.8%-16.6%
5Y-19.8%10Y-30.6%+10.8%
4.3.1.3. Return on Equity

Shows how efficient Invion Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -39.0% Return on Equity means Invion Ltd generated $-0.39 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Invion Ltd:

  • The MRQ is -39.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -39.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.0%TTM-39.0%0.0%
TTM-39.0%YOY-8.8%-30.2%
TTM-39.0%5Y-21.5%-17.4%
5Y-21.5%10Y-48.5%+27.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Invion Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Invion Ltd is operating .

  • Measures how much profit Invion Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -145.8% means the company generated $-1.46  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Invion Ltd:

  • The MRQ is -145.8%. The company is operating very inefficient. -2
  • The TTM is -145.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-145.8%TTM-145.8%0.0%
TTM-145.8%YOY-40.2%-105.7%
TTM-145.8%5Y-70.7%-75.1%
5Y-70.7%10Y-1,310.3%+1,239.6%
4.3.2.2. Operating Ratio

Measures how efficient Invion Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.04 means that the operating costs are $3.04 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Invion Ltd:

  • The MRQ is 3.044. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.044. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.044TTM3.0440.000
TTM3.044YOY1.941+1.103
TTM3.0445Y2.228+0.816
5Y2.22810Y18.919-16.691
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Invion Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Invion Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.05 means the company has $2.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Invion Ltd:

  • The MRQ is 2.053. The company is able to pay all its short-term debts. +1
  • The TTM is 2.053. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.053TTM2.0530.000
TTM2.053YOY8.854-6.801
TTM2.0535Y6.735-4.683
5Y6.73510Y4.026+2.709
4.4.3.2. Quick Ratio

Measures if Invion Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.97 means the company can pay off $1.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Invion Ltd:

  • The MRQ is 1.967. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.967. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.967TTM1.9670.000
TTM1.967YOY8.762-6.795
TTM1.9675Y6.662-4.696
5Y6.66210Y3.943+2.719
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Invion Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Invion Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Invion Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.07 means that Invion Ltd assets are financed with 6.6% credit (debt) and the remaining percentage (100% - 6.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Invion Ltd:

  • The MRQ is 0.066. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.066. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.0660.000
TTM0.066YOY0.034+0.031
TTM0.0665Y0.0660.000
5Y0.06610Y0.205-0.139
4.5.4.2. Debt to Equity Ratio

Measures if Invion Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 7.0% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Invion Ltd:

  • The MRQ is 0.070. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.070. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.070TTM0.0700.000
TTM0.070YOY0.035+0.035
TTM0.0705Y0.073-0.003
5Y0.07310Y0.358-0.285
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Invion Ltd generates.

  • Above 15 is considered overpriced but always compare Invion Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.57 means the investor is paying $-4.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Invion Ltd:

  • The EOD is -154.110. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.566. Based on the earnings, the company is expensive. -2
  • The TTM is -4.566. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-154.110MRQ-4.566-149.544
MRQ-4.566TTM-4.5660.000
TTM-4.566YOY-15.902+11.335
TTM-4.5665Y-27.922+23.355
5Y-27.92210Y-24.749-3.173
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Invion Ltd:

  • The EOD is -262.707. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.784. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.784. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-262.707MRQ-7.784-254.923
MRQ-7.784TTM-7.7840.000
TTM-7.784YOY-5.851-1.933
TTM-7.7845Y-27.391+19.607
5Y-27.39110Y-0.833-26.558
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Invion Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Invion Ltd:

  • The EOD is 60.072. Based on the equity, the company is expensive. -2
  • The MRQ is 1.780. Based on the equity, the company is underpriced. +1
  • The TTM is 1.780. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD60.072MRQ1.780+58.292
MRQ1.780TTM1.7800.000
TTM1.780YOY1.396+0.384
TTM1.7805Y5.816-4.037
5Y5.81610Y6.442-0.625
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Invion Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -4,844278-4,566-6,828-11,394-1,893-13,28613,2860
Net Interest Income  100003434-274-240
Income Tax Expense  000194194-194000



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets15,451
Total Liabilities1,014
Total Stockholder Equity14,438
 As reported
Total Liabilities 1,014
Total Stockholder Equity+ 14,438
Total Assets = 15,451

Assets

Total Assets15,451
Total Current Assets2,081
Long-term Assets13,370
Total Current Assets
Cash And Cash Equivalents 784
Net Receivables 1,210
Other Current Assets 87
Total Current Assets  (as reported)2,081
Total Current Assets  (calculated)2,081
+/- 0
Long-term Assets
Property Plant Equipment 39
Intangible Assets 13,331
Other Assets 0
Long-term Assets  (as reported)13,370
Long-term Assets  (calculated)13,370
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities1,014
Long-term Liabilities0
Total Stockholder Equity14,438
Total Current Liabilities
Accounts payable 721
Other Current Liabilities 293
Total Current Liabilities  (as reported)1,014
Total Current Liabilities  (calculated)1,014
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock148,355
Retained Earnings -136,080
Accumulated Other Comprehensive Income 2,163
Total Stockholder Equity (as reported)14,438
Total Stockholder Equity (calculated)14,438
+/-0
Other
Capital Stock148,355
Cash and Short Term Investments 784
Common Stock Shares Outstanding 6,424,407
Liabilities and Stockholders Equity 15,451
Net Debt -784
Net Invested Capital 14,438
Net Working Capital 1,067
Property Plant and Equipment Gross 39



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-30
> Total Assets 
1,443
1,483
2,064
2,527
13,642
13,947
3,736
3,238
24,317
4,488
4,730
6,829
16,250
14,731
16,099
11,982
5,812
10,349
6,062
5,761
5,642
20,041
19,047
15,451
15,45119,04720,0415,6425,7616,06210,3495,81211,98216,09914,73116,2506,8294,7304,48824,3173,2383,73613,94713,6422,5272,0641,4831,443
   > Total Current Assets 
0
0
0
0
0
2,131
2,649
2,394
23,712
3,761
4,278
6,466
4,766
4,757
4,337
1,167
1,007
3,061
942
917
1,076
8,648
5,761
2,081
2,0815,7618,6481,0769179423,0611,0071,1674,3374,7574,7666,4664,2783,76123,7122,3942,6492,13100000
       Cash And Cash Equivalents 
0
249
137
1,197
1,823
420
156
36
23,647
3,433
3,909
4,185
3,051
3,953
2,285
437
917
2,891
771
619
1,037
8,473
4,085
784
7844,0858,4731,0376197712,8919174372,2853,9533,0514,1853,9093,43323,647361564201,8231,1971372490
       Short-term Investments 
0
1,067
0
0
0
0
1,585
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,58500001,0670
       Net Receivables 
23
84
1,757
160
422
1,135
852
2,301
15
56
28
2,248
1,611
662
1,918
648
32
92
29
272
11
140
1,616
1,210
1,2101,616140112722992326481,9186621,6112,2482856152,3018521,1354221601,7578423
       Other Current Assets 
0
0
0
0
54
50
1,641
56
51
271
341
32
104
142
134
82
57
78
142
26
28
34
60
87
87603428261427857821341421043234127151561,64150540000
   > Long-term Assets 
0
0
0
0
0
11,817
1,087
844
605
727
452
363
11,484
9,907
11,711
10,761
4,805
7,288
5,120
4,844
4,566
11,394
13,286
13,370
13,37013,28611,3944,5664,8445,1207,2884,80510,76111,7119,90711,4843634527276058441,08711,81700000
       Property Plant Equipment 
8
63
139
206
11,181
11,647
911
663
455
233
133
264
17
29
27
6
3
0
5
4
1
0
58
39
3958014503627291726413323345566391111,64711,181206139638
       Intangible Assets 
1,125
0
0
0
0
0
0
0
0
0
0
0
11,323
9,878
11,684
10,756
4,802
7,288
5,115
4,840
4,565
11,393
13,228
13,331
13,33113,22811,3934,5654,8405,1157,2884,80210,75611,6849,87811,323000000000001,125
       Other Assets 
0
0
0
964
162
170
175
182
150
494
319
99
143
67
52
54
0
0
0
0
0
0
0
0
0000000054526714399319494150182175170162964000
> Total Liabilities 
1,403
1,744
1,535
1,936
11,726
9,113
3,020
6,463
12,179
9,265
6,872
816
5,214
4,572
9,239
5,993
1,805
2,443
605
327
851
462
651
1,014
1,0146514628513276052,4431,8055,9939,2394,5725,2148166,8729,26512,1796,4633,0209,11311,7261,9361,5351,7441,403
   > Total Current Liabilities 
278
619
535
936
3,583
2,366
3,001
4,338
10,569
9,154
6,721
678
656
792
4,714
638
1,805
1,782
605
327
851
462
651
1,014
1,0146514628513276051,7821,8056384,7147926566786,7219,15410,5694,3383,0012,3663,583936535619278
       Short-term Debt 
0
0
0
0
0
597
200
273
152
3,617
2,327
0
16
16
2,579
120
1,257
20
50
11
11
0
0
0
000111150201,2571202,579161602,3273,61715227320059700000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
16
2,579
120
1,257
20
0
0
0
0
0
0
000000201,2571202,579160000000000000
       Accounts payable 
176
412
446
883
1,854
1,080
1,855
3,458
5,977
1,124
794
379
466
527
1,705
205
117
568
308
106
449
221
400
721
7214002214491063085681172051,7055274663797941,1245,9773,4581,8551,0801,854883446412176
       Other Current Liabilities 
102
206
90
53
800
489
946
608
2,505
1,231
-2,011
299
173
249
430
313
430
307
297
210
403
241
251
293
293251241403210297307430313430249173299-2,0111,2312,5056089464898005390206102
   > Long-term Liabilities 
0
0
0
0
0
6,747
20
2,125
1,610
111
151
137
4,559
3,779
4,525
1,200
2,487
661
358
117
449
221
0
0
002214491173586612,4871,2004,5253,7794,5591371511111,6102,125206,74700000
       Other Liabilities 
0
0
0
0
34
59
20
2,125
75
111
151
137
29
15
4,525
4,155
0
661
0
0
0
0
0
0
00000066104,1554,5251529137151111752,1252059340000
> Total Stockholder Equity
40
0
529
591
739
2,506
715
-3,225
12,138
-4,777
-2,142
6,013
11,036
10,159
6,860
5,989
4,007
7,906
5,457
5,434
4,791
19,579
18,396
14,438
14,43818,39619,5794,7915,4345,4577,9064,0075,9896,86010,15911,0366,013-2,142-4,77712,138-3,2257152,506739591529040
   Retained Earnings -136,080-130,475-130,836-128,595-127,112-148,218-148,006-143,135-140,936-136,488-123,447-116,563-111,389-105,848-92,168-76,915-62,633-41,618-32,19200000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
3,672
5,494
14,101
18,585
19,100
19,402
20,084
20,191
20,664
23,463
21,386
20,963
23,771
23,120
1,990
2,429
3,871
1,988
2,163
2,1631,9883,8712,4291,99023,12023,77120,96321,38623,46320,66420,19120,08419,40219,10018,58514,1015,4943,67200000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.